Introduction {#s1}
============

Greater trochanteric pain syndrome (GTPS) is thought to be a degenerative condition of the gluteal tendons and bursa[@R1] [@R2] for which few risk factors have been identified. Tendinopathies occur in both sporting and sedentary populations[@R3] indicating a multifactorial aetiology.[@R4]--[@R6] These factors include intrinsic and extrinsic risk factors.[@R5] Identifying risk factors for GTPS should aid in understanding the aetiology of, and direct treatment for, GTPS.

Intrinsic risk factors previously identified for tendinopathies such as patellar and Achilles tendinopathy include genetic and biomechanical factors.[@R7] [@R8] Intrinsic factors associated with GTPS are sex and age,[@R9] [@R10] with older women at greater risk of developing GTPS. Other possible intrinsic factors are adiposity and biomechanics. Elevated adiposity has been proposed as an under recognised risk factor for all tendinopathies[@R11] suggesting a systemic mechanism is involved rather than mechanical overload.[@R6] Peripheral adiposity, (gynoid distribution), appears to be a risk factor for developing tendinopathy in women.[@R12] To date, the level of adiposity in GTPS has only been reported in terms of body mass index (BMI), with values ranging from 22.1 kgm^−213^ to 27.3 kgm^−2^.[@R14] BMI measures the relationship between height and weight but does not indicate fat distribution, a key factor in determining the systemic effects of increased adiposity.[@R15] As there is some evidence to suggest increased adiposity is a risk factor for developing tendinopathy in women, the relationship of adiposity and GTPS deserves further investigation.

Other intrinsic risk factors for developing GTPS that have been reported in review papers and textbooks (in runners) include leg length discrepancy[@R16] and pelvic width.[@R16]--[@R19] However, leg length discrepancy has not been found to be associated with GTPS in people with primary GTPS[@R10] or in people who develop GTPS post-total hip arthroplasty.[@R20] In addition, leg length discrepancy has been reported to be lower in those with GTPS than the population prevalence.[@R21] [@R22] The evidence of pelvic width as a risk factor is limited to level V evidence,[@R16] [@R17] with the authors failing to differentiate between the pelvic, hip or greater trochanter width. As GTPS is more common in women, and women have wider pelves than men,[@R23] the research question of whether a wider pelvis is an intrinsic risk factor for GTPS should be addressed.

Pathological compression of a tendon is thought to contribute to the development of tendinopathy.[@R24]--[@R26] The angle that the tendon approaches the enthesis and the size of the bony pulley before the tendon insertion affects the strain and compression forces on the tendon. In the case of the gluteus medius and minimus tendons, this angle is in part determined by the neck shaft angle of the femur. In addition, greater hip width at the level of the greater trochanters would result in the gluteal tendons wrapping over a greater proportion of the greater trochanter, leading to an increased area of compression.[@R27] Therefore, the degree of coxa vara and the pelvic width at the level of the greater trochanter may be a predisposing factor for developing GTPS.[@R24]--[@R26]

The aims of this study were to evaluate if the width of the pelvis or femoral neck shaft angle constituted independent risk factors, or if in combination of these constituted a risk factor for developing GTPS. A further aim was to determine if increased adiposity and the distribution pattern of the adiposity was associated with GTPS.

Participants and methods {#s2}
========================

Participants {#s3}
------------

Four groups of participants were recruited; those with GTPS, gluteal tendon reconstruction (GTR; surgical management of GTPS), hip osteoarthritis (OA) and an age and sex matched (to the GTPS group) control group (ASC). Participants were recruited through private healthcare providers and viva voce. All participants had to be older than 18 years of age and able to communicate in English. Participants were excluded if they had the following: systemic inflammatory disease, for example, rheumatoid arthritis; lumbar spine nerve root signs; a history of lumbar spine or ipsilateral hip joint surgery; osteogenic disease, for example, Paget\'s disease, or neoplastic disease. Due to sex-linked pelvic morphology, men were excluded from this study.[@R23]

Hip OA participants were diagnosed according to Altman 1991[@R28] and were scheduled for hip arthroplasty surgery. Diagnostic criteria for GTPS was a history of lateral hip pain,[@R22] [@R29] pain on palpation of the greater trochanter and at least one of lateral hip pain with lying on the ipsilateral side, weight bearing activities or sitting.[@R29] [@R30] In addition to the above criteria for GTPS, participants in the GTR group had evidence of tendon tearing on MRI or ultrasound imaging, with symptoms refractory to ultrasound-guided corticosteroid injection and physiotherapy. Control participants had to be asymptomatic for hip joint and tendon pathology. Participants in the GTPS, GTR and ASC groups had no evidence of hip OA.[@R28] Participants in the ASC and OA groups had no past or current history of GTPS. Clinical status was confirmed by examination using the above criteria (AF). Hip joint status was confirmed via x-ray or MRI.

Ethical approval for this study was provided by the Australian National University, ACT Health, Calvary HealthCare and Deakin University human research ethics committees. All participants provided informed consent.

Methods {#s4}
=======

The study was undertaken between February 2004 and November 2009. Two hundred and twenty potential participants were contacted. Within the GTPS group, 40 people were contacted, 10 were excluded, and one withdrew (n=29). Within the GTR group, 35 potential participants were contacted, and four were excluded (n=31). Eleven were assessed preoperatively; the remainder were assessed an average of 22 months postoperatively. Details of the latter group have been previously reported.[@R1] Within the ASC group, 40 people were contacted, 18 were excluded (n=22). Within the OA group, 126 people were contacted, 23 declined, 73 were excluded (n=20).

Participants had a standardised anterior to posterior x-ray in supine, centred on the pubis. The x-rays were digitised and deidentified. Pelvic morphology was assessed by measures of lateral pelvic dimensions and the acetabular index using Intellicad 2000 for Microsoft windows (IntelliCAD technology consortium, Visio Corporation). Lateral measures were taken from the midline -- a perpendicular line that bisected the distance between the distal border of the acetabular tear drops (ML) to the anterior inferior iliac spine (AIIS) (A); to the lateral rim of the acetabulum (B); to the most superior aspect of the greater trochanter (C); and to the most lateral aspect of the greater trochanter (D) ([figure 1](#F1){ref-type="fig"}). Ratio distances in relation to A were calculated for linear measures. The acetabular index was measured according to Sharp\'s method[@R31] ([figure 1](#F1){ref-type="fig"}). The femoral neck shaft angle was measured using a six-inch goniometer (<http://www.physiosupplies.com.au> 15 May 2011) on the digital x-ray, aligning the goniometer arms along the shaft and neck of the femur. Measurements were undertaken by one of two assessors (AF, SS). To test the reliability of measurements, each rater measured an identical set of 20 deidentified x-rays twice, 1 week apart.

![Schematic illustration of the lines used to measure the width of the pelvis and greater trochanters, and the acetabular index. The midline was defined as the line perpendicular and bisecting the line that joined to two tear drops. (A) The width from the midline to the anterior inferior iliac spine -- the reference width. (B) The width from the midline to the most lateral aspect of the acetabulum. (C) The width from the midline to the most superior point of the greater trochanter. (D) The width from the midline to the most lateral aspect of the greater trochanter.](bjsports-2011-090744f01){#F1}

Physical examination {#s5}
--------------------

Ninety nine participants had standard waist and hip girth measurements taken (AF). In standing, using a non-stretch tape measure, the waist measure was taken on light expiration at the narrowest point,[@R32] (or the mid point between the ribs and the iliac crest when the narrowest point was not identifiable). The hip measure was taken at the largest elevation about the buttocks;[@R32] [@R33] and at the greater trochanter, across both greater trochanters with the tape measure parallel to the ground. Height and weight were measured with the participants in light clothing and no shoes. Height was measured using a wall-mounted stadiometer (Menton Education Centre, Moorabbin, <http://mentone-educational.com.au>). Weight was measured on flat medical quality scales (Hills scale service, Baulkham Hills, NSW. <http://www.hillscales.com.au>).

Data analysis {#s6}
-------------

Statistical analyses were performed with Stata IC 10.1 (Statacorp, USA). Reliability was assessed using an intraclass correlation co-efficient (ICC). Between group, differences were compared using a one-way analysis of variance (ANOVA) with posthoc Scheffe analysis. Linear models were used to test group differences between the affected and unaffected lower limbs. In cases of bilateral symptoms, the more symptomatic lower limb was designated the affected side. Analysis by side led to the same conclusions regarding group differences, thus the mean neck of femur neck shaft angle and acetabular index from both sides is reported. Between group differences were calculated for the neck shaft angle and acetabular index using a linear mixed-model analysis. p Values of \<0.05 were considered significant. Using a posthoc cut off of 134° for neck shaft angle, logistic regression was used to assess group differences in the prevalence of a neck shaft angle less than 134°, OR (95% CI) relative to the asymptomatic group are reported. A canonical linear discriminant analysis (CDA) was undertaken to explore group differences in relation to multiple variables. All variables were included in the CDA analysis.

Results {#s7}
=======

Participants {#s8}
------------

The OA participants were the oldest cohort, with a mean (SD) age of 62 (13.3) years. In contrast, the mean ages for the ASC, GTPS and GTR groups were 51.6, 52.2 and 55.7 years, respectively ([table 1](#T1){ref-type="table"}).

###### 

Demographic data and x-ray and anthropometric data availability by group

                                                                           ASC (n=22)    GTPS (n=29)    GTR (n=31)    OA (n=20)
  ------------------------------------------------------------------------ ------------- -------------- ------------- --------------
  Age (years): mean (SD)[\*](#T1FN1){ref-type="table-fn"}                  51.6(10.19)   52.2 (12.85)   55.7 (9.13)   62.0 (13.28)
  Duration of symptom: mean (SD, months)[†](#T1FN2){ref-type="table-fn"}   0             61.9 (60.2)    44.4 (37.4)   40.3 (43.9)
  X-ray reports                                                            20/22         28/29          31/31         20/20
  X-ray images[‡](#T1FN3){ref-type="table-fn"}                             20/22         28/29          21/31         20/20
  Anthropometric data                                                      22/22         28/29          30/31         20/20

ACS, asymptomatic control group; GTPS, greater trochanteric pain syndrome group; GTR, gluteal tendon reconstruction group; OA, hip osteoarthritis group.

p\<0.05, one way analysis of variance.

No group difference between the symptomatic groups. The GTR group data are for the 11 prospectively enrolled participants. The remaining GTR participants were evaluated a mean of 22 months postoperatively.

Missing x-rays: one ASC and one GTPS participant did not consent to x-ray; X-ray imaging was missing for one ASC and 10 GTR participants. X-ray or MRI reports were available for all participants confirming the status of the joint.

Inter and intratester reliability {#s9}
---------------------------------

Good to excellent intra and intertester reliability was demonstrated for all imaging measures, greater than 0.70 being considered good.[@R34] [@R35] The intrarater ICC ranged from (95% CI) of 0.72 (0.62 to 0.80) to 1.0 (1.0 to 1.0) and the interrater ICC range (95% CI) of 0.77 (0.72 to 0.82) to 0.99 (0.98 to 1.0) (table S1, table S2).

Bony morphology {#s10}
---------------

The neck shaft angle was lower in the GTR participants than in any other group ([table 2](#T2){ref-type="table"}). No difference was demonstrated between the GTPS, OA or ASC groups. The OR (95% CI) of having a neck shaft angle of less than 134°, relative to the ASC group was highest for the GTR group at 3.33 (1.26 to 8.85); 1.4 (0.52 to 3.75) for the GTPS; and 0.85 (0.28 to 2.61) for the OA group. The OR of GTR relative to GTPS was 2.4 (1.01 to 5.6). No group difference was found for the acetabular index, any measure of pelvic width, or the distance from the superior greater trochanter to the lateral greater trochanter ([table 2](#T2){ref-type="table"}).

###### 

Bony morphology measures of the pelvis. Acetabular index, neck shaft angle, pelvic and greater trochanter widths. Results by group (mean, 95% CI)

  Measure                        ASC (n=20)               GTPS (n=28)              GTR (n=21)               OA (n=20)                ANOVA (p values)
  ------------------------------ ------------------------ ------------------------ ------------------------ ------------------------ ----------------------------------------
  Neck-shaft angle°              137.2 (135.1 to 139.4)   137.1 (135.2 to 139.0)   133.1 (131.0 to 135.2)   137.0 (134.8 to 139.1)   0.021[\*](#T2FN1){ref-type="table-fn"}
  Acetabular index°              41.3 (39.8 to 42.9)      39.9 (38.6 to 41.3)      39.7 (38.2 to 41.3)      41.9 (40.3 to 43.5)      0.129
  Acetabular width (A:B)         1.14 (1.10 to 1.17)      1.14 (1.08 to 1.20)      1.16 (0.93 to 1.40)      1.14 (1.00 to 1.27)      0.737
  Superior GT width (A:C)        0.87 (0.83 to 0.91)      0.91 (0.89 to 0.93)      0.90 (0.0.86 to 0.94)    0.87 (0.82 to 0.92)      0.208
  Lateral GT width (A:D)         1.30 (1.25 to 1.35)      1.32 (1.27 to 1.37)      1.36 (1.29 to 1.43)      1.31 (1.26 to 1.36)      0.455
  Superior to lateral GT (C:D)   1.49 (1.44 to 1.54)      1.45 (1.41 to 1.49)      1.50 (1.47 to 1.53)      1.52 (1.44 to 1.60)      0.221

ACS, asymptomatic control group; ANOVA, analysis of variance; GTPS, greater trochanteric pain syndrome group; GTR, gluteal tendon reconstruction group; OA, hip osteoarthritis group.

Posthoc analysis found that the GTR group has a lower neck-shaft angle than the OA group (p=0.012), the GTPS group (p=0.005) and the ASC group (p=0.007). No other group comparisons approached significance.

A is the distance from the midline to the AIIS. B is the distance from the midline to the lateral acetabulum. C is the distance from the midline to the most superior point of the greater trochanter. D is the distance from the midline to the most lateral aspect of the greater trochanter.

Anthropometric measurements {#s11}
---------------------------

There was statistically significant difference across the groups in greater tronchanter girth measurements (ANOVA: p=0.036, [table 3](#T3){ref-type="table"}). GTPS group had the highest, and the ASC group had the lowest, greater trochanter girth measurements. However, posthoc analysis failed to demonstrate pair-wise differences. There was a trend towards group differences for hip girth measurement, with the GTPS group having the highest mean girth (ANOVA: p=0.090, [table 3](#T3){ref-type="table"}). There were no group differences for waist girth and BMI measurements ([table 3](#T3){ref-type="table"}).

###### 

Results of anthropometric measurements. Group (mean, 95% CI)

  Measurement            ASC (n=22)              GTPS (n=27)              GTR (n=30)               OA (n=20)                ANOVA (p values)
  ---------------------- ----------------------- ------------------------ ------------------------ ------------------------ ----------------------------------------
  BMI (kgm^−2^)          25.0 (23.5 to 26.5)     27.5 (25.4 to 29.6)      26.8 (25.2 to 28.4)      25.3 (23.5 to 27.1)      0.154
  Waist girth (cm) (W)   83.0 (78.9 to 87.1)     88.4 (82.9 to 93.9)      84.6 (79.6 to 89.6)      84.0 (79.0 to 89.0)      0.420
  Hip girth (cm) (H)     102.8 (99.4 to 106.2)   109.1 (104.9 to 113.2)   105.9 (100.0 to 109.2)   104.2 (100.0 to 108.4)   0.090
  GT girth (cm (GTg))    99.1 (94.7 to 103.5)    105.9 (100.2 to 111.6)   103.8 (100.3 to 107.3)   100.3 (96.7 to 103.9)    0.036[\*](#T3FN1){ref-type="table-fn"}
  W:H                    0.81 (0.783 to 0.837)   0.79 (0.753 to 0.827)    0.80 (0.764 to 0.836)    0.81 (0.781 to 0.839)    0.884
  W:GTg                  0.85 (0.791 to 0.909)   0.84 (0.797 to 0.883)    0.82 (0.772 to 0.868)    0.84 (0.791 to 0.886)    0.855

ACS, asymptomatic control group; ANOVA, analysis of variance; BMI, body mass index; GTg, greater trochanter girth; GTPS, greater trochanteric pain syndrome group; GTR, gluteal tendon reconstruction group; H, hip girth; OA, hip osteoarthritis group; W, waist girth.

Posthoc analysis showed a trend for the GTPS group to be larger about the greater trochanters than the ASC group, but pair wise analyses failed to demonstrate group differences, p=0.079. None of the other measures approached significance.

Canonical discriminant analysis {#s12}
-------------------------------

Using canonical discriminant analysis (CDA), the measures of adiposity and increased width at the superior greater trochanter were found to be relevant in discriminating across the four groups. The CDA had one out of three dimensions that was statistically significant (p=0.048, 0.458 and 0.782 respectively; table S3). The statistically significant dimension had positive means for GTR (0.18) and GTPS (0.82), and negative means for OA (−0.66) and ASC (−0.68) (table S4). This dimension (dimension 1, [table 4](#T4){ref-type="table"}) represents gynoid adiposity, and width at the level of the superior GT, but not the lateral GT ([table 4](#T4){ref-type="table"}). The analysis confirms that overall adiposity, with a gynoid distribution is a factor in discriminating between the groups. These results are interpreted to mean that gynoid adiposity combined with increased width at the level of the superior greater trochanter were associated with, and may be risk factors for, GTPS and GTR.

###### 

Canonical (discriminant) loading

                                  Dimension 1
  ------------------------------- -------------
  Adiposity measures              
   **BMI**                        **0.45**
   Waist girth                    0.28
   **Hip girth**                  **0.53**
   **GT girth**                   **0.50**
   Waist girth to hip girth       −0.10
   Waist girth to GT girth        −0.01
  Bony measures                   
   NoF angle                      −0.19
   Acetabulum width (A:B)         0.08
   **Superior GT width (A:C)**    **0.34**
   Lateral GT width (A:D))        0.14
   Superior to lateral GT (C:D)   −0.28

BMI, body mass index; GT, greater trochanter; NoF, neck of femur.

Refer to text for descriptions of A--D. As the measures of adiposity and pelvic width at the GT are all positive with hip girth, superior GT girth and BMI loading the dimension the most (in bold). Dimension 1 was interpreted to be the combination of gluteofemoral adiposity and width of the superior GT.

Discussion {#s13}
==========

GTPS is a common condition in older women for which few risk factors have been identified. This study aimed to establish if features of bony morphology of the pelvis or hip constitute a risk for this condition. In addition, overall adiposity and a lower femoral neck shaft angle was evaluated as associated factors. We found that increased coxa vara was a risk factor for having gluteal tendon reconstruction surgery for refractory GTPS ([table 2](#T2){ref-type="table"}). Further, we found that higher levels of adiposity and increased width at the level of the superior greater trochanter were associated with both GTPS and GTR participants ([tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}).

Women who underwent gluteal tendon reconstructive surgery demonstrated lower neck shaft angles than women in the other groups ([table 2](#T2){ref-type="table"}). This novel finding may explain why some women have a more severe and persistent presentation of GTPS. Finite element modelling has shown that the iliotibial band applies more medial pressure over the greater trochanter in femurs with lower neck shaft angles than in those with higher neck shaft angles.[@R27] Along with medial compression of the tendon against the greater trochanter, lateral pressure from the iliotibial band is likely to result in increased compression of the gluteus medius tendon, resulting in tendinopathy and eventual tendon rupture.[@R36]--[@R38]

Furthermore, the difference in biomechanics may contribute to the breakdown of the gluteal tendons via pathological loading of the tendon. The lower angle likely results in an increase in the load taken by the gluteus medius tendon as the lever arm is likely to be relatively shortened: we found no overall increase in width at the level of the greater trochanter, thus the resultant geometry supports this conclusion. This likely leads to increased extracellular matrix turnover that may result in tendinopathy.[@R39] The combination of increased compression and load fits the tendinopathy model proposed by Cook and Purdam.[@R40] [@R41]

The assessment of adiposity demonstrated that the women with GTPS and GTR had a trend towards larger girth measurements at the waist and hip, and were larger at the greater trochanter level. These trends support the previous findings that women with increased adiposity, particularly gynoid adiposity, are at risk of tendinopathy.[@R12]

The common assertion that women who develop GTPS have wider hips is supported by this study, albeit in an unexpected way. On univariate analysis, women with GTPS did not have a wider bony pelvis or hips than women without GTPS. Rather, in those women who went on to have surgery, the lower neck shaft angle combined with the increased gynoid adipose tissue results in the outward appearance of wider hips. Women with GTPS who did not go on to have surgery, and had a normal neck shaft angle also had higher levels of gynoid adiposity, thus would appear wider.

Higher levels of adiposity within the GTPS and GTR groups were confirmed by the canonical discriminant analysis. This analysis found that the GTPS and GTR groups had higher group means than either the ASC or OA groups on the dimension which reflects adiposity, with a higher influence of the gynoid than the central adiposity. Like Gaida *et al* who found gynoid adiposity had a stronger association with tendinopathy in women than central adiposity,[@R12] our study found higher levels of gynoid adiposity in the GTPS and GTR groups than the other two groups -- although pair-wise analysis failed to show group differences. As with Gaida *et al*, there was no difference between the groups with respect to BMI. BMI is known to be a simple but insensitive measure of adiposity.[@R15] The results of this study, and those of Gaida *et al*,[@R12] suggest that in addition to BMI, measures of adiposity distribution should be reported in musculoskeletal studies.[@R42] [@R43] We note that gynoid adipocyte accumulation and tendinopathy are associated in women in general and GTPS in particular.[@R11] We propose that there may be local adipokine and bioactive peptide activity that contributes to the development of tendinopathy.[@R44]

The mean neck shaft angle was larger for the entire population sample than has been previously reported (125° to 133°).[@R45]--[@R47] Differences in the mean neck shaft angle could be due to method variations. In the current study, the assessors used similar methods as previously reported[@R45]--[@R49] and demonstrated good to excellent inter and intratester reliability. This study was undertaken on actual patients as opposed to previous studies that were completed on x-rays of, or directly from, anatomical or cadaveric specimens (with only one paper reporting reliability).[@R48] This suggests that measure of neck shaft angle taken from specimens may not translate to the live patient. As neck shaft angle lowers with age[@R48] cadaveric specimens are likely to have lower neck shaft angles than the general population. A further difference may be that the cohort in this study of all female pelves had a systematic bias for a lower neck shaft angle. A previous study noted that lower neck shaft angles are associated with higher levels of weight bearing,[@R48] it is conceivable that the small sample is from a less active sample population than previous studies -- which included measures from historic data. Regardless, people who underwent GTR have a lower neck shaft angle than the comparison groups ([table 2](#T2){ref-type="table"}).

The following limitations of this study are acknowledged. This sample population was relatively small and from one geographic location. Further research should address both these issues, thus determining a robust neck shaft angle cut off, or population-specific cut offs. A further limitation is the case-control design. The adiposity results would be stronger had a prospective study been undertaken. The results demonstrate that the OA group had a lower level of adiposity, and in a different distribution, than the other two symptomatic groups. This result is despite probably low levels of activity in all three symptomatic groups. This suggests that undertaking a longitudinal study to evaluate if adiposity is a modifiable risk factor (rather than an association) would be valuable.

Further research into the biomechanics of the hip and pelvis, compression of the tissues around the GT and the relationship of adiposity to tendinopathy should be pursued. As the hip acts in three dimensions, examining the biomechanics of the hip joint axis of movement, trochanteric height, neck shaft angle and femoral anteversion in people who develop GTPS, would assist in understanding the mechanism of aetiology, and direct mechanical treatments.

The results from this study provide a clinical indicator (a lower neck shaft angle) for patients who may fail to respond to non-operative treatment of GTPS. Researchers in the musculoskeletal area should include measures of central and peripheral adiposity in addition to BMI.

Conclusions {#s14}
===========

The development of GTPS is likely to be multifactorial in nature. Women with GTPS appear wider at the hips than women without GTPS due to increased levels of peripheral adiposity and, in some cases, lower femoral neck shaft angles, rather than differences in bony width of the pelvis or hips. We found that women with gluteal tendon tears and with a lower femoral neck shaft angle are more at risk of failure of conservative management than those with a normal neck shaft angle. We also found that increased gynoid adiposity and pelvic width at the level of the superior aspect of the greater trochanter was associated with GTPS, supporting previous findings that gynoid adiposity is associated with tendinopathy.

###### What this study adds

-   The measure of a neck shaft angles of \<134° identifies those at risk of failing conservative treatment.

-   Confirmation of the findings that peripheral adiposity is associated with the development of tendinopathy in women.

-   Wider greater trochanter (superior aspect) and increased adiposity combine to increase the risk of GTPS. This may be due to increased internal compression and shear combined with adiposity-related systemic effects.
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